Tolbutamide
Orinase, Tolbutamide (tolbutamide) is a small molecule pharmaceutical. Tolbutamide was first approved as Orinase on 1982-01-01. It is used to treat type 2 diabetes mellitus in the USA. The pharmaceutical is active against ATP-sensitive inward rectifier potassium channel 11. In addition, it is known to target ATP-sensitive inward rectifier potassium channel 11 and ATP-sensitive inward rectifier potassium channel 8.
Trade Name | Orinase, Tolbutamide |
---|---|
Common Name | Tolbutamide |
Indication | type 2 diabetes mellitus |
Drug Class |